Eriksen Bjørn Odvar, Stefansson Vidar Tor Nyborg, Jenssen Trond Geir, Mathisen Ulla Dorte, Schei Jørgen, Solbu Marit Dahl, Wilsgaard Tom, Melsom Toralf
From the Metabolic and Renal Research Group (B.O.E., V.T.N.S., T.G.J., U.D.M., J.S., M.D.S., T.M.), Department of Community Medicine, Faculty of Health Sciences (T.W.), UiT The Arctic University of Norway; Section of Nephrology, University Hospital of North Norway (B.O.E., U.D.M., M.D.S., T.M.); and Department of Transplant Medicine, Oslo University Hospital, Norway (T.G.J.).
Hypertension. 2017 Apr;69(4):651-659. doi: 10.1161/HYPERTENSIONAHA.117.09020. Epub 2017 Feb 21.
Arterial stiffness is a risk factor for cardiovascular and chronic kidney disease. However, the role of arterial stiffness as a predictor of the age-related glomerular filtration rate (GFR) decline in the general population remains unresolved because of difficulty in measuring GFR with sufficient precision in epidemiological studies. The ambulatory arterial stiffness index (AASI) is a proposed indicator of arterial stiffness easily calculated from ambulatory blood pressure. We investigated whether AASI could predict GFR decline measured as iohexol clearance in the general population. We calculated AASI from baseline ambulatory blood pressure and measured the iohexol clearance at baseline and follow-up in the RENIS-FU study (Renal Iohexol Clearance Survey Follow-Up). AASI was defined as 1 minus the regression slope of the diastolic blood pressure measurement over the systolic blood pressure measurement for each patient. The RENIS cohort included a representative sample of the general middle-aged population without baseline diabetes mellitus, cardiovascular disease, or kidney disease (n=1608). The participant age was 50 to 62 years old at baseline, and the median observation time was 5.6 years. The mean (SD) of the GFR decline rate was 0.95 mL/min per year (2.23) and that of the AASI was 0.38 mL/min per year (0.13). Baseline ambulatory blood pressure or the night/day systolic or diastolic ambulatory blood pressure ratios were not associated with GFR decline. In multivariable-adjusted linear mixed regression analysis, 1 SD of increase in the baseline AASI was associated with a 0.14 mL/min per year (95% confidence interval, -0.26 to -0.02) steeper GFR decline. We conclude that the AASI is an independent risk factor for accelerated age-related GFR decline in the general middle-aged population.
动脉僵硬度是心血管疾病和慢性肾脏病的一个危险因素。然而,由于在流行病学研究中难以足够精确地测量肾小球滤过率(GFR),动脉僵硬度作为一般人群中与年龄相关的GFR下降预测指标的作用仍未明确。动态动脉僵硬度指数(AASI)是一种从动态血压中容易计算出来的动脉僵硬度指标。我们调查了AASI是否能够预测一般人群中以碘海醇清除率衡量的GFR下降情况。我们在RENIS-FU研究(肾碘海醇清除率调查随访)中根据基线动态血压计算AASI,并在基线和随访时测量碘海醇清除率。AASI被定义为每个患者舒张压测量值相对于收缩压测量值的回归斜率的相反数。RENIS队列包括一般中年人群中无基线糖尿病、心血管疾病或肾脏疾病的代表性样本(n = 1608)。参与者在基线时年龄为50至62岁,中位观察时间为5.6年。GFR下降率的均值(标准差)为每年0.95 mL/min(2.23),AASI的均值(标准差)为每年0.38 mL/min(0.13)。基线动态血压或夜间/日间收缩压或舒张压动态血压比值与GFR下降无关。在多变量调整的线性混合回归分析中,基线AASI每增加1个标准差与每年0.14 mL/min(95%置信区间,-0.26至-0.02)更陡峭的GFR下降相关。我们得出结论,AASI是一般中年人群中与年龄相关的GFR加速下降的独立危险因素。